Filtros de búsqueda

Lista de obras de Vera Magistroni

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants

artículo científico publicado en 2008

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene

artículo científico publicado en 2015

CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data

artículo científico publicado en 2013

Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of -Catenin, KRAS, and the Oncogenic Transcription Factor ITF2

artículo científico publicado en 2010

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

artículo científico publicado en 2019

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.

artículo científico publicado en 2015

ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells

artículo científico publicado en 2011

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

artículo científico publicado en 2010

Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.

artículo científico publicado en 2013

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

artículo científico publicado en 2012

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

artículo científico publicado en 2013

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells

artículo científico publicado en 2006

RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients

scholarly article by Rocco Piazza et al published 17 November 2015 in American Journal of Hematology

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

artículo científico publicado en 2014

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

artículo científico publicado en 2013

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.

artículo científico publicado en 2018

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

artículo científico publicado en 2017

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years

artículo científico publicado en 2006

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors

artículo científico publicado en 2012

Valproic acid enhances bosutinib cytotoxicity in colon cancer cells

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda